Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Clinical Immunology (Orlando, Fla.)|April 22, 2019
Treatment of murine lupus with TIGIT-IgShuowu Liu, Lizhu Sun, Chuqi Wang, et al.Oncotarget|January 31, 2015
Molecular architecture of the ErbB2 extracellular domain homodimerShi Hu, Yuna Sun, Yanchun Meng, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2019
EGFR/Notch Antagonists Enhance the Response to Inhibitors of the PI3K-Akt Pathway by Decreasing Tumor-Initiating Cell FrequencyWenyan Fu, Changhai Lei, Yue Yu, et al.Science Translational Medicine|March 10, 2017
Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequencyShi Hu, Wenyan Fu, Tian Li, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 20, 2019
Targeting RyR2 with a phosphorylation site-specific nanobody reverses dysfunction of failing cardiomyocytes in ratsTian Li, Yafeng Shen, Fangxing Lin, et al.Frontiers in Immunology|April 12, 2021
A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus NephritisWenyan Fu, Yu Liu, Fangjie Liu, et al.Frontiers in Immunology|January 3, 2022
Corrigendum: A Novel Autoantibody Induced by Bacterial Biofilm Conserved Components Aggravates Lupus NephritisWenyan Fu, Yu Liu, Fangjie Liu, et al.Nature Communications|September 27, 2019
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicityWenyan Fu, Changhai Lei, Shuowu Liu, et al.Cancer Letters|August 30, 2016
Broad RTK-targeted therapy overcomes molecular heterogeneity-driven resistance to cetuximab via vectored immunoprophylaxis in colorectal cancerShi Hu, Haibin Dai, Tian Li, et al.Advanced Materials (Deerfield Beach, Fla.)|September 26, 2019
NaCl Nanoparticles as a Cancer TherapeuticWen Jiang, Lei Yin, Hongmin Chen, et al.Pageof 7